Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Yanjing Pharmaceutical is a specialized pharmaceutical manufacturer based in Beijing, China, and a key subsidiary of China Resources Double-Crane Pharmaceutical. Established in 1989, the company has grown into a significant global supplier of Active Pharmaceutical Ingredients (APIs), particularly Vitamin B1 (Thiamine) and xanthine derivatives such as Theophylline and Aminophylline. Its product portfolio primarily addresses therapeutic needs in respiratory health, cardiovascular diseases, and nutritional supplementation. The company operates large-scale manufacturing facilities that comply with international GMP standards, supporting both domestic supply and global exports. As part of the China Resources Pharmaceutical Group, it leverages extensive resources for the production of high-quality finished dosage forms and chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Yanjing Pharmaceutical.